Ortho RTi Commences Pivotal Study in Rotator Cuff Repair

Ortho Regenerative Technologies (Ortho RTi) initiated a six-month pivotal animal study on Ortho-R biopolymer for rotator cuff repair. A pre-Investigational New Drug meeting is scheduled with FDA to formalize requirements for the filing of an application to commence human trials on Ortho-R.

Three-month results from the animal study are expected...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us